Cleared Traditional

K221351 - Mechanical Guidewire

K221351 is an FDA 510(k) clearance for Mechanical Guidewire, manufactured by Baylis Medical Company, Inc.. The device is a Class 2 Cardiovascular device with product code DQX cleared through the Traditional 510(k) pathway after a 223-day FDA review.

K221351 · Baylis Medical Company, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2022
Decision
223d
Days
Class 2
Risk

K221351 is an FDA 510(k) clearance for the Mechanical Guidewire. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Baylis Medical Company, Inc. (Mississauga, CA). The FDA issued a Cleared decision on December 19, 2022 after a review of 223 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Baylis Medical Company, Inc. devices

FDA 510(k) Submission Details - K221351

510(k) Number K221351 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 10, 2022
Decision Date December 19, 2022
Days to Decision 223 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d slower than avg
Panel avg: 125d · This submission: 223d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQX Device Classification - Class 2, Special Controls

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 681
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K221351.
BNLE Access Guidewire
K221390 · Biomerics Nle · Apr 2023
Vassallo GT 018 Hybrid
K223432 · Filmecc Co., Ltd. · Mar 2023
ProTrack Pigtail Wire
K213898 · Baylis Medical Company, Inc. · Mar 2023
VASSALLO GT EXT
K222631 · Filmecc Co., Ltd. · Oct 2022
Pre-Formed Blue
K221575 · Lake Region Medical · Oct 2022
EpiFaith CV
K212615 · Flat Medical Co., Ltd. · Sep 2022